DOC · 00Consultation Dossier
Forensic Clinical Report.
NHS-inspired consultation dossier — printable cardiovascular intelligence compiled for your physician.
DETECTIVES HEALTH · CONSULTATION DOSSIER
Cardiovascular Intelligence Report
PATIENT
[Your Name]
REPORT DATE
12 MAY 2026
PREPARED BY
Steve Diongo, BMS · NHS Labs
SECTION 01 · EXECUTIVE SUMMARY
Composite cardiovascular signature indicates a Grey Zone resilience profile driven by atherogenic lipoprotein burden, low-grade vascular inflammation, and emergent metabolic drift. No critical lab findings require urgent intervention; pattern-level investigation is recommended.
SECTION 02 · FLAGGED BIOMARKERS
| MARKER | VALUE | OPTIMAL | STATUS |
|---|---|---|---|
LDL Cholesterol LDL-C | 3.6 mmol/L | < 2.6 | GREY ZONE |
HDL Cholesterol HDL-C | 1.1 mmol/L | > 1.5 | GREY ZONE |
Triglycerides TG | 2.1 mmol/L | < 1.0 | CRITICAL DRIFT |
Total Cholesterol TC | 5.7 mmol/L | < 5.0 | GREY ZONE |
Apolipoprotein B ApoB | 1.18 g/L | < 0.80 | GREY ZONE |
Non-HDL Cholesterol Non-HDL | 4.6 mmol/L | < 3.4 | CRITICAL DRIFT |
HbA1c HbA1c | 41 mmol/mol | < 36 | GREY ZONE |
Fasting Glucose FPG | 5.6 mmol/L | < 5.0 | GREY ZONE |
Fasting Insulin FI | 12 mIU/L | < 6 | GREY ZONE |
High-Sensitivity CRP hs-CRP | 3.1 mg/L | < 1.0 | CRITICAL DRIFT |
Erythrocyte Sedimentation Rate ESR | 14 mm/hr | < 10 | GREY ZONE |
Ferritin Ferritin | 320 µg/L | 30 – 200 | GREY ZONE |
Blood Pressure BP | 138 / 86 mmHg | < 120 / 80 | GREY ZONE |
Waist Circumference WC | 96 cm | < 94 | GREY ZONE |
Recovery Capacity HRV | 42 ms | > 60 | GREY ZONE |
SECTION 03 · ACTIVE CASE FILES
- CASE-001 · OPENED APR 02Lipid Investigation ActiveAtherogenic particle burden trending upward across two consecutive panels.
- CASE-002 · OPENED APR 08Inflammatory Burden MonitoringVascular inflammation signature requires source attribution.
- CASE-003 · OPENED APR 11Metabolic Stress DetectedInsulin and triglyceride drift concurrent — early resilience loss.
- CASE-004 · OPENED APR 19Vascular Loading PatternPressure / adiposity convergence under review.
SECTION 04 · SUGGESTED GP DISCUSSION PROMPTS
- Could ApoB and Lp(a) be added to refine atherogenic particle assessment?
- Given persistent hs-CRP elevation, what inflammatory source attribution is appropriate?
- Should fasting insulin and HOMA-IR be tracked alongside HbA1c?
- Would 24-hour ambulatory blood pressure monitoring clarify vascular loading?
EDUCATIONAL DOCUMENT · NOT A DIAGNOSTIC INSTRUMENT · PREPARED TO SUPPORT CLINICAL CONSULTATION